As 25 May 2018 approaches businesses in the Life Sciences sector should be preparing for the new General Data Protection Regulation (“GDPR”) which builds on the UK Data Protection Act 1998 and invokes data protection best practice.  Read more (PDF DOWNLOAD)

Industry is eagerly awaiting the UK Supreme Court judgment of this month's hearing on whether a rule that constitutes a serious obstacle to enforcing patents for important medicines will be removed or modified, say legal experts Charlotte Tillett and Camille Arnold in the Pink Sheet (subscription required). 

With a large number of businesses in the Life Sciences sector relying on migrant labour, employers should be aware of the hostile immigration environment and how easy it is for their employees to become accidentally illegal. Jackie Penlington considers the issues in Real Business.  Read more

The Competition and Markets Authority (“CMA”) currently has a large number of ongoing investigations in the “healthcare and medical equipment” and “pharmaceuticals” sectors. We look at some of the recent cases.  Read more

In the latest on the relocation of the European Medicines Agency (EMA), it has been reported that Italy intends to challenge the decision to move the EMA from London to Amsterdam after Brexit. Read more

6 March 2018

We will be hosting a construction case law update at One Great George Street, London SW1, where we’ll be identifying the latest legal developments in this fast moving area of law.  Please see our event page or contact Leticia Lagarda for further information. 

25 April 2018

Members of our Life Sciences team will be attending the Medicines for Europe - Legal Affairs conference in London. Find out more

15 - 17 May 2018

We will be at the EU Pharmaceutical Law Forum in Brussels as one of the conference sponsors. Please get in touch with Charlotte Tillett or Gustaf Duhs to arrange a catch up. Find out more